SciVision Biotech Inc. (TPE:1786)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
58.30
-2.30 (-3.80%)
Apr 29, 2026, 1:30 PM CST
-37.85%
Market Cap 4.53B
Revenue (ttm) 886.62M
Net Income (ttm) 162.34M
Shares Out 74.83M
EPS (ttm) 2.18
PE Ratio 27.82
Forward PE n/a
Dividend 3.25 (5.36%)
Ex-Dividend Date Apr 29, 2026
Volume 447,813
Average Volume 349,138
Open 57.80
Previous Close 60.60
Day's Range 57.00 - 58.50
52-Week Range 57.20 - 124.00
Beta 0.61
RSI 33.50
Earnings Date May 8, 2026

About SciVision Biotech

SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan. [Read more]

Sector Healthcare
Founded 1990
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1786
Full Company Profile

Financial Performance

In 2025, SciVision Biotech's revenue was 886.62 million, an increase of 0.37% compared to the previous year's 883.31 million. Earnings were 162.34 million, a decrease of -32.99%.

Financial Statements

News

There is no news available yet.